Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-21 Sale | 2025-03-25 4:10 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 9,766 | $293.36 | $2,864,985 | 20,902 (Indirect Direct) | View |
| 2025-03-24 Sale | 2025-03-25 4:09 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 7,440 | $299 | $2,224,560 | 28,036 (Indirect Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:22 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 2,755 | $242.94 | $669,304 | 21,857 (Indirect Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:22 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 471 | $243.78 | $114,820 | 35,830 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:21 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 2,557 | $242.92 | $621,150 | 33,042 (Indirect Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:21 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,264 | $243.78 | $308,141 | 57,608 (Indirect Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:20 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 3,877 | $243.79 | $945,165 | 135,335 (Indirect Direct) | View |
| 2025-02-28 Sale | 2025-03-03 4:32 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 2,900 | $241.69 | $700,894 | 90,875 (Indirect Direct) | View |
| 2025-02-28 Sale | 2025-03-03 4:31 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 796 | $241.7 | $192,390 | 35,863 (Indirect Direct) | View |
| 2025-02-28 Sale | 2025-03-03 4:31 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 513 | $241.68 | $123,983 | 16,011 (Direct) | View |
| 2025-02-28 Sale | 2025-03-03 4:31 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 935 | $241.69 | $225,977 | 15,551 (Indirect Direct) | View |
| 2025-02-28 Sale | 2025-03-03 4:30 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 496 | $241.69 | $119,878 | 12,922 (Indirect Direct) | View |
| 2025-02-14 Sale | 2025-02-18 4:49 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 1,213 | $255.17 | $309,527 | 81,933 (Indirect Direct) | View |
| 2025-02-14 Sale | 2025-02-18 4:47 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 967 | $255.17 | $246,750 | 32,843 (Indirect Direct) | View |
| 2025-02-14 Sale | 2025-02-18 4:47 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 2,103 | $252.71 | $531,448 | 13,418 (Indirect Direct) | View |
| 2025-02-14 Sale | 2025-02-18 4:47 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 3,109 | $253.43 | $787,904 | 12,670 (Indirect Direct) | View |
| 2025-01-27 Sale | 2025-01-29 4:03 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 52,592 | $285 | $14,988,720 | 12,670 (Indirect Direct) | View |
| 2025-01-23 Sale | 2025-01-24 4:10 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director | 11,250 | $275 | $3,093,750 | 266,899 (Indirect Direct) | View |
| 2024-12-12 Sale | 2024-12-13 4:13 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 1,752 | $251 | $439,760 | 16,386 (Indirect Direct) | View |
| 2024-11-26 Sale | 2024-11-27 5:22 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 5,219 | $250.98 | $1,309,853 | 79,287 (Indirect Direct) | View |
| 2024-11-26 Sale | 2024-11-27 5:22 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 1,682 | $250.98 | $422,144 | 18,138 (Indirect Direct) | View |
| 2024-11-26 Sale | 2024-11-27 5:21 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,682 | $250.98 | $422,144 | 30,701 (Indirect Direct) | View |
| 2024-11-26 Sale | 2024-11-27 5:21 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,469 | $250.98 | $368,686 | 13,191 (Direct) | View |
| 2024-11-26 Sale | 2024-11-27 5:20 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 3,000 | $251.65 | $754,947 | 13,418 (Indirect Direct) | View |
| 2024-08-20 Sale | 2024-08-22 8:01 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 15,000 | $280 | $4,200,000 | 76,200 (Indirect Direct) | View |
| 2024-08-12 Sale | 2024-08-14 4:12 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 22,025 | $270.99 | $5,968,516 | 15,610 (Indirect Direct) | View |
| 2024-08-06 Sale | 2024-08-08 4:10 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director | 20,250 | $262 | $5,305,586 | 3,636 (Indirect Direct) | View |
| 2024-08-01 Sale | 2024-08-02 8:01 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 15,148 | $270 | $4,089,960 | 91,200 (Indirect Direct) | View |
| 2024-07-11 Sale | 2024-07-12 8:02 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 7,093 | $261 | $1,851,273 | 73,848 (Indirect Direct) | View |
| 2024-06-25 Sale | 2024-06-27 4:04 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 8,500 | $240 | $2,040,000 | 11,186 (Direct) | View |
| 2024-06-24 Sale | 2024-06-26 4:28 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 32,450 | $220.69 | $7,161,360 | 43,086 (Indirect Direct) | View |
| 2024-06-25 Sale | 2024-06-26 4:28 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 2,103 | $230.99 | $485,773 | 16,290 (Indirect Direct) | View |
| 2024-06-25 Sale | 2024-06-26 4:27 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 8,301 | $230.99 | $1,917,475 | 80,941 (Indirect Direct) | View |
| 2024-06-25 Sale | 2024-06-26 4:26 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,605 | $231 | $370,747 | 28,949 (Indirect Direct) | View |
| 2024-06-25 Sale | 2024-06-26 4:26 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,605 | $231 | $370,747 | 11,660 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-24 Exercise | 2025-03-25 4:10 pm | N/A 2026-12-20 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 5,445 | $0 | 20,902 (Direct) | View |
| 2025-03-24 Exercise | 2025-03-25 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 5,445 | $42.22 | 20,902 (Direct) | View |
| 2025-03-24 Exercise | 2025-03-25 4:09 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 7,440 | $88.95 | 28,036 (Direct) | View |
| 2025-03-24 Exercise | 2025-03-25 4:09 pm | N/A 2025-12-18 | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 7,440 | $0 | 28,036 (Direct) | View |
| 2025-03-13 Exercise | 2025-03-14 4:16 pm | 2016-06-01 2025-06-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 2,750 | $0 | 11,186 (Direct) | View |
| 2025-03-13 Exercise | 2025-03-14 4:16 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 2,750 | $131.21 | 11,186 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 4:23 pm | N/A 2035-03-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Hesslein Robert W. EVP, CLO and Secretary | 2,286 | $0 | 9,531 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 4:22 pm | N/A 2035-03-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 11,690 | $0 | 21,857 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 4:22 pm | N/A 2035-03-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 21,956 | $0 | 35,830 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 4:21 pm | N/A 2035-03-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 21,956 | $0 | 33,042 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 4:21 pm | N/A 2035-03-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 24,917 | $0 | 57,608 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 4:20 pm | N/A 2035-03-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 54,258 | $0 | 135,335 (Direct) | View |
| 2025-02-27 Exercise | 2025-03-03 4:32 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 5,921 | $0 | 90,875 (Direct) | View |
| 2025-02-27 Exercise | 2025-03-03 4:31 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,908 | $0 | 35,863 (Direct) | View |
| 2025-02-27 Exercise | 2025-03-03 4:31 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,667 | $0 | 16,011 (Direct) | View |
| 2025-02-27 Exercise | 2025-03-03 4:31 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 1,908 | $0 | 15,551 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-18 4:49 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 3,859 | $0 | 81,933 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-18 4:47 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,109 | $0 | 32,843 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-18 4:47 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 2,103 | $0 | 13,418 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-18 4:47 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 3,109 | $0 | 12,670 (Direct) | View |
| 2025-01-27 Exercise | 2025-01-29 4:03 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 48,876 | $88.95 | 12,670 (Direct) | View |
| 2025-01-27 Exercise | 2025-01-29 4:03 pm | 2019-08-06 2025-12-18 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 48,876 | $0 | 12,670 (Direct) | View |
| 2025-01-23 Exercise | 2025-01-24 4:10 pm | 2016-06-01 2025-06-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director | 11,250 | $0 | 266,899 (Direct) | View |
| 2025-01-23 Exercise | 2025-01-24 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director | 11,250 | $131.21 | 266,899 (Direct) | View |
| 2024-11-25 Option Award | 2024-11-27 5:22 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 10,658 | $0 | 79,287 (Direct) | View |
| 2024-11-25 Option Award | 2024-11-27 5:22 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 3,434 | $0 | 18,138 (Direct) | View |
| 2024-11-25 Option Award | 2024-11-27 5:21 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,434 | $0 | 30,701 (Direct) | View |
| 2024-11-25 Option Award | 2024-11-27 5:21 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 3,000 | $0 | 13,191 (Direct) | View |
| 2024-11-25 Option Award | 2024-11-27 5:20 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 3,000 | $0 | 13,418 (Direct) | View |
| 2024-10-08 Option Award | 2024-10-10 4:06 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 96 | $0 | 16,386 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-03 4:11 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Hesslein Robert W. EVP, CLO and Secretary | 7,245 | $0 | 7,245 (Direct) | View |
| 2024-08-20 Exercise | 2024-08-22 8:01 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 15,000 | $85 | 76,200 (Direct) | View |
| 2024-08-20 Exercise | 2024-08-22 8:01 pm | N/A 2029-02-27 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 15,000 | $0 | 76,200 (Direct) | View |
| 2024-08-12 Exercise | 2024-08-14 4:12 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 14,058 | $85 | 15,610 (Direct) | View |
| 2024-08-12 Exercise | 2024-08-14 4:12 pm | N/A 2029-02-28 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 20,725 | $0 | 15,610 (Direct) | View |
| 2024-08-12 Exercise | 2024-08-14 4:12 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 6,667 | $97.72 | 15,610 (Direct) | View |
| 2024-08-06 Exercise | 2024-08-08 4:10 pm | 2019-06-20 2028-06-19 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director | 20,250 | $0 | 3,636 (Direct) | View |
| 2024-08-06 Exercise | 2024-08-08 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director | 11,250 | $131.21 | 3,636 (Direct) | View |
| 2024-08-06 Exercise | 2024-08-08 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director | 9,000 | $105.26 | 3,636 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-02 8:01 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 15,148 | $85 | 91,200 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-02 8:01 pm | N/A 2029-02-27 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 15,148 | $0 | 91,200 (Direct) | View |
| 2024-06-25 Exercise | 2024-06-27 4:04 pm | 2016-06-01 2025-06-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 8,500 | $0 | 11,186 (Direct) | View |
| 2024-06-25 Exercise | 2024-06-27 4:04 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 8,500 | $131.21 | 11,186 (Direct) | View |
| 2024-06-24 Exercise | 2024-06-26 4:28 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 17,560 | $88.95 | 43,086 (Direct) | View |
| 2024-06-24 Exercise | 2024-06-26 4:28 pm | 2017-06-03 2026-06-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 32,450 | $0 | 43,086 (Direct) | View |
| 2024-06-24 Exercise | 2024-06-26 4:28 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 7,420 | $70.2 | 43,086 (Direct) | View |
| 2024-06-24 Exercise | 2024-06-26 4:28 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 7,470 | $71.99 | 43,086 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 4:28 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 4,295 | $0 | 16,290 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 4:27 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 16,953 | $0 | 80,941 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 4:26 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,278 | $0 | 28,949 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 4:26 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 3,278 | $0 | 11,660 (Direct) | View |